Pharmacology  ·  Cholinergic Pharmacology

Irreversible Acetylcholinesterase Inhibitors, Organophosphate Toxicology, and Cholinergic Toxidrome Management

Phosphorylation, aging, the full toxidrome, antidote pharmacology, and carbamate comparison


Abbreviations: AChE = acetylcholinesterase  ·  NMJ = neuromuscular junction  ·  BBB = blood-brain barrier  ·  2-PAM = pralidoxime  ·  GABA = gamma-aminobutyric acid  ·  SLUDGE = salivation, lacrimation, urination, defecation, GI distress, emesis

Organophosphate Inhibition and the Aging Phenomenon

Mechanism and Time Dependency
Mechanism of Inhibition
  • Organophosphate attacks the active site serine of AChE
  • Forms a covalent phosphoryl-enzyme bond
  • Bond hydrolyzed millions of times more slowly than normal
  • ACh accumulates at all cholinergic synapses
  • Both muscarinic and nicotinic receptors continuously stimulated
The Aging Reaction
  • After phosphorylation, spontaneous dealkylation occurs
  • Converts the adduct to a form resistant to oxime reactivation
  • Once aged: permanently inhibited — no antidote can restore the enzyme
  • Rate is compound-specific — determines the pralidoxime window
  • Recovery requires synthesis of new enzyme (days to weeks)
Aging Half-Lives — Window for Pralidoxime (relative scale)
Soman (GD)
2–6 minutes
Sarin (GB)
3–5 hours
VX
36–48 hours
Pesticide organophosphates
12–36+ hours

The Cholinergic Toxidrome — Three Components

Muscarinic, Nicotinic, and CNS Effects
Muscarinic (SLUDGE)
  • Salivation
  • Lacrimation
  • Urination
  • Defecation / diarrhea
  • GI cramping
  • Emesis
  • Miosis
  • Bronchospasm — life-threatening
  • Bronchorrhea — life-threatening
  • Bradycardia — life-threatening
  • Diaphoresis
Nicotinic (NMJ & Ganglia)
  • Fasciculations (early)
  • Muscle weakness (progresses)
  • Flaccid paralysis (severe)
  • Respiratory muscle failure
  • Ganglia: initial tachycardia and hypertension
  • Progresses to bradycardia as parasympathetic dominates
  • Not reversed by atropine
  • Addressed by pralidoxime
Central Nervous System
  • Anxiety, agitation
  • Cognitive impairment
  • Seizures
  • Loss of consciousness
  • Central respiratory depression
  • Coma in severe poisoning
  • Atropine crosses BBB: treats this component
  • Pralidoxime does NOT cross BBB
Cause 1 NMJ Blockade Depolarizing paralysis of diaphragm and intercostal muscles
Cause 2 Bronchospasm M3 receptor-mediated airway smooth muscle contraction
Cause 3 Bronchorrhea M3 receptor-mediated gland hypersecretion flooding the airways
Cause 4 Central Depression CNS AChE inhibition suppressing the medullary respiratory center

Atropine addresses causes 2, 3, and 4 (muscarinic and CNS). Mechanical ventilation is the only intervention that addresses all four simultaneously.

The Antidote Triad — Three Targets, Three Drugs

Atropine, Pralidoxime, and Benzodiazepines
Atropine Competitive muscarinic receptor antagonist (all subtypes). Blocks bronchospasm, bronchorrhea, bradycardia, and other parasympathetic effects. Crosses the BBB (tertiary amine). Titrate to secretion drying, NOT to heart rate.
Does NOT reverse NMJ paralysis. Does NOT reactivate AChE. Large doses required in severe poisoning.
Pralidoxime (2-PAM) Oxime nucleophile that reactivates phosphorylated AChE by displacing the phosphoryl group. Time-dependent: ineffective after aging. Addresses nicotinic effects at the NMJ. Does NOT cross the BBB (quaternary compound).
Give as early as possible. Continue 24–48 hours in pesticide poisoning. Not indicated for carbamate poisoning.
Benzodiazepines Enhance GABA-A receptor chloride conductance. Suppress seizures by hyperpolarizing neurons. Remain effective even after muscarinic blockade is complete, because late-phase seizures are glutamate-driven. Diazepam, lorazepam, or midazolam.
Treat promptly: delay allows progression to self-sustaining status epilepticus. Use prophylactically in moderate to severe poisoning.

Organophosphates vs. Carbamates — Key Differences

Critical Management Distinction
Feature Organophosphates Carbamates
Mechanism Phosphorylation of active site serine Carbamylation of active site serine
Aging Yes — adduct becomes permanently resistant to pralidoxime over time No — carbamyl adduct spontaneously hydrolyzes (30–120 min half-life)
Enzyme Recovery Only with pralidoxime (before aging) or synthesis of new enzyme Spontaneous, without antidote
Pralidoxime Indicated — give early and continue 24–48 hours Not indicated — may be harmful; enzyme recovers on its own
Atropine Required — titrate to secretion drying Required — same titration principle; dose requirements typically lower
Clinical Course Potentially prolonged; redistribution from tissue stores can cause relapse Shorter and more self-limited; symptoms typically resolve in 6–24 hours
Toxidrome Full cholinergic toxidrome Full cholinergic toxidrome (identical presentation)

Suggested References

Author / OrganizationTitleSource
Katzung BG (ed) Basic and Clinical Pharmacology, 15th ed. McGraw-Hill, 2021
Brunton LL, Knollmann BC (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th ed. McGraw-Hill, 2023
Colovic MB, Krstic DZ, Lazarevic-Pasti TD, et al Acetylcholinesterase inhibitors: pharmacology and toxicology Curr Neuropharmacol. 2013;11(3):315–335
Eddleston M, Buckley NA, Eyer P, Dawson AH Management of acute organophosphorus pesticide poisoning Lancet. 2008;371(9612):597–607
Karalliedde L, Senanayake N Organophosphorus insecticide poisoning Br J Anaesth. 1989;63(6):736–750
Jokanovic M Medical treatment of acute poisoning with organophosphorus and carbamate pesticides Toxicol Lett. 2009;190(2):107–115
Holstege CP, Kirk M, Sidell FR Chemical warfare: nerve agent poisoning Crit Care Clin. 1997;13(4):923–942
Eddleston M, Eyer P, Worek F, et al Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study Lancet. 2005;366(9495):1452–1459
Treiman DM GABAergic mechanisms in epilepsy Epilepsia. 2001;42(Suppl 3):8–12
Reigart JR, Roberts JR Recognition and Management of Pesticide Poisonings, 6th ed. US Environmental Protection Agency, 2013
Worek F, Thiermann H, Wille T Oximes in organophosphate poisoning: 60 years of hope and despair Chem Biol Interact. 2016;259(Pt B):93–98
Thiermann H, Worek F, Kehe K Limitations and challenges in treatment of acute chemical warfare agent poisoning Chem Biol Interact. 2013;206(3):435–443
Bradberry SM, Cage SA, Proudfoot AT, Vale JA Poisoning due to pyrethroids Toxicol Rev. 2005;24(2):93–106
Munoz-Quezada MT, Lucero BA, Iglesias VP, et al Chronic exposure to organophosphate pesticides and neuropsychological functioning in farm workers Int J Occup Environ Health. 2016;22(1):68–79